Security key
92790C104
Viridian Therapeutics, Inc.DE - Common Stock (VRDN)
CUSIP: 92790C104
Q2 2021 13F Holders as of 30 Jun 2021
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 6,003,456
- Total 13F value
- $109,804,000
- Share change
- +946,243
- SEC-reported price per share
- $18.29
- Number of holders
- 24
- Value change
- +$18,416,912
- Number of buys
- 14
- Number of sells
- 12
- Shares outstanding
- 101,911,273
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2021
Institutions
24
Top holders
10
VRDN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2021
Previous quarter: Q1 2021
Viridian Therapeutics, Inc.\DE SEC filings
Viridian Therapeutics, Inc.\DE company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92790C104
Recent filing periods:
Ownership snapshot
Top reported holders of VRDN - Viridian Therapeutics, Inc.DE - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ally Bridge Group (NY) LLC
Disclosed value leader
Ally Bridge Group (NY) LLC
Comparable rows
15/15
Latest evidence
31 Mar 2021
13F
Lead comparable stake: 0.67%
Showing 1-6 of 15 holder rows.
Quick read
Ally Bridge Group (NY) LLC leads the comparable SEC ownership view at 0.67%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ally Bridge Group (NY) LLC's linked filing trail.
Comparable ownership
Top 5
Ally Bridge Group (NY) LLC
0.67%
WELLINGTON MANAGEMENT GROUP LLP
0.57%
Logos Global Management LP
0.54%
BVF INC/IL
0.45%
Cormorant Asset Management, LP
0.45%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ally Bridge Group (NY) LLC |
13F
Company
|
0.67%
|
$11,376,000
680,768 shares
|
— | 31 Mar 2021 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
0.57%
|
$9,668,000
578,560 shares
|
— | 31 Mar 2021 |
| Logos Global Management LP |
13F
Company
|
0.54%
|
$9,191,000
550,000 shares
|
— | 31 Mar 2021 |
| BVF INC/IL |
13F
Company
|
0.45%
|
$7,745,000
463,504 shares
|
— | 31 Mar 2021 |
| Cormorant Asset Management, LP |
13F
Company
|
0.45%
|
$7,672,000
459,144 shares
|
— | 31 Mar 2021 |
| Point72 Asset Management, L.P. |
13F
Company
|
0.39%
|
$6,609,000
395,534 shares
|
— | 31 Mar 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
24
Shares
6,003,456
Rows available
24
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
28
Q2 2021 holders
24
Holder diff
-4
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q2 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend